<DOC>
	<DOCNO>NCT01467271</DOCNO>
	<brief_summary>The main purpose study prospectively estimate incidence NSF patient moderate severe renal impairment administration DOTAREM®</brief_summary>
	<brief_title>Observational Study Incidence NSF Renal Impaired Patients Following DOTAREM Administration</brief_title>
	<detailed_description>All patient follow 2 year DOTAREM® administration collect data suspect NSF NSF relate symptom</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Patients moderate severe end stage renal impairment dialysis , schedule contrast enhance MRI DOTAREM Patient receive Gadolinium Based Contrast Agent within past 12 month prior inclusion study except GBCA receive Dotarem</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>